Can you provide the last earnings date for CARDINAL HEALTH INC?
CARDINAL HEALTH INC (CAH) last reported earnings on 2/5/2026.
CARDINAL HEALTH INC (CAH) Earnings History & Surprises
NYSE:CAH • US14149Y1082
Current stock price
207.83 USD
-3.09 (-1.47%)
At close:
209 USD
+1.17 (+0.56%)
After Hours:
CAH Earnings overview
Past quarterly earnings results for CARDINAL HEALTH INC (CAH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 29, 2026
- Period
- Q3 / 2026
- EPS Estimate
- $2.80
- Revenue Estimate
- 62.338B
Last Reported
Most Recent- Release Date
- Feb 5, 2026
- Period
- Q2 / 2026
- EPS Reported
- $2.63
- EPS Surprise
- 9.42%
- Revenue Surprise
- 1.38%
Beat Rate
Last 8 Quarters 75%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 2.63 | 2.40 | 9.42% | 36.27% | 65.627B | 64.734B | 1.38% | 18.75% |
| Q1 2026 | 2.55 | 2.20 | 15.85% | 35.64% | 64.009B | 59.789B | 7.06% | 22.44% |
| Q4 2025 | 2.08 | 2.06 | 1.06% | 13.04% | 60.159B | 61.48B | -2.15% | 0.49% |
| Q3 2025 | 2.35 | 2.19 | 7.37% | 12.98% | 54.878B | 55.907B | -1.84% | -0.06% |
| Q2 2025 | 1.93 | 1.78 | 8.65% | 6.04% | 55.264B | 55.567B | -0.55% | -3.80% |
| Q1 2025 | 1.88 | 1.63 | 15.13% | 8.67% | 52.277B | 51.404B | 1.70% | -4.54% |
| Q4 2024 | 1.84 | 1.76 | 4.62% | 18.71% | 59.867B | 59.285B | 0.98% | 12.00% |
| Q3 2024 | 2.08 | 1.97 | 5.55% | 19.54% | 54.911B | 56.615B | -3.01% | 8.76% |
| Q2 2024 | 1.82 | 1.62 | 12.64% | 37.88% | 57.445B | 57.583B | -0.24% | 11.61% |
| Q1 2024 | 1.73 | 1.42 | 21.95% | 44.17% | 54.763B | 55.306B | -0.98% | 10.40% |
| Q4 2023 | 1.55 | 1.51 | 2.66% | 47.62% | 53.453B | 53.246B | 0.39% | 13.57% |
| Q3 2023 | 1.74 | 1.50 | 15.83% | 20.00% | 50.487B | 50.206B | 0.56% | 12.60% |
| Q2 2023 | 1.32 | 1.15 | 14.85% | 3.94% | 51.469B | 51.251B | 0.43% | 13.23% |
| Q1 2023 | 1.20 | 0.95 | 26.10% | -6.98% | 49.603B | 48.668B | 1.92% | 12.82% |
| Q4 2022 | 1.05 | 1.19 | -11.53% | -19.23% | 47.065B | 45.161B | 4.22% | 10.52% |
| Q3 2022 | 1.45 | 1.54 | -5.87% | -5.23% | 44.836B | 43.591B | 2.86% | 14.16% |
| Q2 2022 | 1.27 | 1.24 | 2.45% | -27.01% | 45.457B | 46.028B | -1.24% | 9.43% |
| Q1 2022 | 1.29 | 1.34 | -3.68% | -14.57% | 43.968B | 42.352B | 3.82% | 12.55% |
| Q4 2021 | 1.30 | 1.21 | 7.29% | 25.00% | 42.586B | 40.828B | 4.31% | 16.07% |
| Q3 2021 | 1.53 | 1.57 | -2.38% | -5.56% | 39.275B | 40.494B | -3.01% | 0.30% |
| Q2 2021 | 1.74 | 1.46 | 19.40% | 14.47% | 41.541B | 41.852B | -0.74% | 4.55% |
| Q1 2021 | 1.51 | 1.14 | 31.93% | 18.90% | 39.065B | 38.559B | 1.31% | 4.62% |
| Q4 2020 | 1.04 | 0.93 | 12.43% | - | 36.689B | 37.04B | -0.95% | - |
| Q3 2020 | 1.62 | 1.45 | 11.94% | - | 39.157B | 37.316B | 4.93% | - |
| Q2 2020 | 1.52 | 1.23 | 23.28% | - | 39.735B | 39.826B | -0.23% | - |
| Q1 2020 | 1.27 | 1.11 | 14.87% | - | 37.341B | 37.115B | 0.61% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
8.42%
Max EPS beat (4)
15.85%
Min EPS beat (4)
1.06%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
1.11%
Max Revenue beat (4)
7.06%
Min Revenue beat (4)
-2.15%
Analysis
In the last 4 quarters, CAH has consistently beaten EPS estimates in all releases
CAH has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, CAH has beaten the EPS estimates by 8.4% on average.
In the last 4 quarters, CAH has beaten the revenue estimates by 1.1% on average.
Related analysis
CARDINAL HEALTH INC / CAH Earnings FAQ
Did CAH stock beat earnings estimates in the most recent quarter?
CARDINAL HEALTH INC (CAH) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does CARDINAL HEALTH INC (CAH) beat earnings estimates?
In the last 4 quarters, CARDINAL HEALTH INC (CAH) has beaten EPS estimates in 4 out of 4 releases.